Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy
- PMID: 9466530
- DOI: 10.1086/514207
Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy
Abstract
Polymerase chain reaction (PCR) and ligase chain reaction (LCR) were compared for the diagnosis of Chlamydia trachomatis infections by testing urine specimens from 408 high school female students. After therapy, sequential urine specimens were tested to determine persistence of chlamydial DNA in urine. Baseline PCR of cervical specimens was positive in 53 (13.0%) students, and PCR and LCR of urine specimens were positive in 63 (15.4%) and 60 (14.7%), respectively. After discrepant analysis, 64 (15.7%) patients could be confirmed as truly infected. Follow-up urine specimens from 33 infected patients demonstrated that at 1-3 days after therapy, PCR and LCR were positive for 40% and 73.3%, respectively. Only at 15 days after therapy did all specimens test negative. Urine tests for Chlamydia organisms should not be used as a test of cure within 3 weeks after treatment. Use of urine assays for screening sexually active adolescents has the potential to significantly improve control of chlamydial infections.
Similar articles
-
A school-based Chlamydia control program using DNA amplification technology.Pediatrics. 1998 Jan;101(1):E1. doi: 10.1542/peds.101.1.e1. Pediatrics. 1998. PMID: 9417165
-
Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women.Mol Cell Probes. 1997 Aug;11(4):243-9. doi: 10.1006/mcpr.1997.0109. Mol Cell Probes. 1997. PMID: 9281409 Clinical Trial.
-
Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction.J Clin Microbiol. 1995 Apr;33(4):898-900. doi: 10.1128/jcm.33.4.898-900.1995. J Clin Microbiol. 1995. PMID: 7790456 Free PMC article.
-
DNA amplification assays: a new standard for diagnosis of Chlamydia trachomatis infections.Ann Acad Med Singap. 1995 Jul;24(4):627-33. Ann Acad Med Singap. 1995. PMID: 8849200 Review.
-
Chlamydia trachomatis infections: progress and problems.J Infect Dis. 1999 Mar;179 Suppl 2:S380-3. doi: 10.1086/513844. J Infect Dis. 1999. PMID: 10081511 Review.
Cited by
-
Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.J Clin Microbiol. 1999 Oct;37(10):3092-6. doi: 10.1128/JCM.37.10.3092-3096.1999. J Clin Microbiol. 1999. PMID: 10488159 Free PMC article.
-
Evaluation of a modified sanitary napkin as a sample self-collection device for the detection of genital chlamydial infection in women.J Clin Microbiol. 2001 Jul;39(7):2508-12. doi: 10.1128/JCM.39.7.2508-2512.2001. J Clin Microbiol. 2001. PMID: 11427561 Free PMC article.
-
Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19. MMWR Recomm Rep. 2014. PMID: 24622331 Free PMC article.
-
Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers.Sex Transm Dis. 2008 Mar;35(3):233-7. doi: 10.1097/OLQ.0b013e31815c11fe. Sex Transm Dis. 2008. PMID: 18490866 Free PMC article.
-
Chlamydia-related knowledge, opinion to opportunistic testing, and practices of providers among different sexually transmitted infections related departments in hospitals in Shenzhen city, China.BMC Health Serv Res. 2022 May 4;22(1):601. doi: 10.1186/s12913-022-08012-3. BMC Health Serv Res. 2022. PMID: 35509056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical